Search results
UK Government Snubs GSK in Favor of Pfizer’s Rival RSV Shot
Bloomberg· 14 hours agoHave a confidential tip for our reporters? GSK Plc has lost out to Pfizer Inc. on a contract to...
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 4 days agoPfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
2 Beaten-Down Growth Stocks to Buy Without Hesitation in the 2024 Bull Market
Motley Fool via Yahoo Finance· 14 hours agoHere are two such companies to keep in mind if you have cash on hand to invest that you don't need...
Analysts Set Pfizer Inc. (NYSE:PFE) Price Target at $35.86
ETF DAILY NEWS· 5 days agoPfizer Inc. (NYSE:PFE – Get Free Report) has been assigned an average rating of “Hold” from the fifteen ratings firms that are currently covering the stock, MarketBeat Ratings ...
Alnylam Stock Pops on Surprising Results From a Key Heart Disease Drug
Barrons.com· 11 hours ago-CM, who took their drug vutrisiran saw a statistically significant reduction in death and recurrent...
Alnylam Rockets On 'Best-Case Scenario' For Pfizer-Rivaling Heart Drug
Investor's Business Daily· 13 hours agoAlnylam Pharmaceuticals (ALNY) tested vutrisiran over three years in patients with ATTR amyloidosis...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 4 days agoDespite a bevy of promising updates for its cancer treatments, Pfizer stock remained trapped below a...
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
The Motley Fool via AOL· 6 days agoWhen it comes to investing in high-yield dividend stocks in the pharmaceutical space, two prominent...
Alnylam Soars After Drug Meets Goal in Heart Disease Trial
Bloomberg via Yahoo Finance· 11 hours ago(Bloomberg) -- Alnylam Pharmaceuticals Inc. shares soared after its drug succeeded in treating a...
Pfizer (NYSE:PFE) Trading 1.3% Higher
ETF DAILY NEWS· 5 days agoPfizer Inc. (NYSE:PFE – Get Free Report) traded up 1.3% on Tuesday . The company traded as high as $27.38 and last traded at $27.32. 8,155,528 shares changed hands during ...